Literature DB >> 32065978

Cutaneous squamous cell carcinoma in the organ transplant recipient.

Kristin Bibee1, Andrew Swartz2, Shaum Sridharan3, Cornelius H L Kurten4, Charles B Wessel5, Heath Skinner6, Dan P Zandberg7.   

Abstract

One in twenty solid organ transplant recipients (SOTRs) will develop a highly morbid or fatal cutaneous carcinoma after transplantation. The majority of these cases develop on the head and neck and may require intervention on the part of dermatology, dermatologic surgery, otolaryngology, transplant medicine, radiation oncology, and medical oncology. In this review, we discuss the problem of cutaneous squamous cell carcinoma (cSCC) in SOTRs as well as the prognostic factors and management strategies to care for this population.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cutaneous head and neck cancer; Immunosuppression; Immunotherapy; Squamous cell carcinoma; Transplant

Mesh：

Year:  2020        PMID： 32065978      PMCID： PMC7217490          DOI： 10.1016/j.oraloncology.2019.104562

Source DB:  PubMed          Journal:  Oral Oncol        ISSN： 1368-8375            Impact factor:   5.337


  110 in total

1.  The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients.

Authors:  Christopher Metchnikoff; Thaddeus Mully; Jonathan P Singer; Jeffrey A Golden; Sarah T Arron
Journal:  J Am Acad Dermatol       Date:  2012-01-29       Impact factor: 11.527

2.  Evaluation of frozen section margins in high-risk cutaneous squamous cell carcinomas of the head and neck.

Authors:  Kyle J Chambers; Stefan Kraft; Kevin Emerick
Journal:  Laryngoscope       Date:  2014-09-17       Impact factor: 3.325

3.  Immune checkpoint inhibitor therapy in a liver transplant recipient with a rare subtype of melanoma: a case report and literature review.

Authors:  James C Kuo; Leslie B Lilly; David Hogg
Journal:  Melanoma Res       Date:  2018-02       Impact factor: 3.599

4.  Tolerability of immune checkpoint inhibition cancer therapy in a cardiac transplant patient.

Authors:  B R Gastman; M S Ernstoff
Journal:  Ann Oncol       Date:  2016-08-08       Impact factor: 32.976

5.  Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma of the head and neck.

Authors:  Michael P Wu; Rosh K V Sethi; Kevin S Emerick
Journal:  Laryngoscope       Date:  2019-03-07       Impact factor: 3.325

6.  Duration of voriconazole exposure: an independent risk factor for skin cancer after lung transplantation.

Authors:  Fiona O Zwald; Margaret Spratt; Bianca D Lemos; Emir Veledar; Clint Lawrence; George Marshall Lyon; Suephy C Chen
Journal:  Dermatol Surg       Date:  2012-05-02       Impact factor: 3.398

7.  Primary prevention of skin dysplasia in renal transplant recipients with photodynamic therapy: a randomized controlled trial.

Authors:  K Togsverd-Bo; S H Omland; H C Wulf; S S Sørensen; M Haedersdal
Journal:  Am J Transplant       Date:  2015-05-27       Impact factor: 8.086

8.  Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma.

Authors:  Evan J Lipson; Mabel A Bodell; Edward S Kraus; William H Sharfman
Journal:  J Clin Oncol       Date:  2014-02-03       Impact factor: 44.544

9.  The efficacy and safety of topical 5% 5-fluorouracil in renal transplant recipients for the treatment of actinic keratoses.

Authors:  Annabel I Ingham; Warren Weightman
Journal:  Australas J Dermatol       Date:  2014-03-13       Impact factor: 2.875

Review 10.  Safe Administration of An Anti-PD-1 Antibody to Kidney-transplant Patients: 2 Clinical Cases and Review of the Literature.

Authors:  Julia K Winkler; Ralf Gutzmer; Carolin Bender; Nina Lang; Martin Zeier; Alexander H Enk; Jessica C Hassel
Journal:  J Immunother       Date:  2017 Nov/Dec       Impact factor: 4.456
View more
  2 in total

Review 1.  Hide-and-seek: Neurotropic squamous cell carcinoma of the periorbital region - a series of five cases and review of the literature.

Authors:  Evi M Morandi; Tina Rauchenwald; Petra Puelzl; Bernhard W Zelger; Bettina G Zelger; Benjamin Henninger; Gerhard Pierer; Dolores Wolfram
Journal:  J Dtsch Dermatol Ges       Date:  2021-11       Impact factor: 5.231

2.  Natural Killer Cell Recognition and Control of Epithelial Cancers.

Authors:  Marcelo de Souza Fernandez Pereira; David R Carr; Margaret E Gatti-Mays; Mallery R Olsen; Bhuvana A Setty; Kathryn T Shahwan; Dean A Lee
Journal:  Cancer J       Date:  2022 Jul-Aug 01       Impact factor: 2.074
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.